Pyrophosphate
- Product NDC
- 51808-218
- 11-digit product format
- 518080218
- Labeler code
- 51808
- Product ID
- 51808-218_e247d821-b132-4a87-a71a-8bc13c71fcfc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pyrophosphate
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- AnazaoHealth Corporation
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2012-05-23
- Marketing end
- 0000-00-00
- Substance
- SODIUM PYROPHOSPHATE
- Active strength
- 28 mg/1
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51808-218-01 | Pyrophosphate | 1 in 1 KIT | INJECTION, POWDER, LYOPHILIZED, | 1 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| SODIUM PYROPHOSPHATE | ACTIVE INGREDIENT | O352864B8Z | PYROPHOSPHATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ANAZAOHEALTH CORPORATION] | 1 | |
| PYROPHOSPHORIC ACID | ACTIVE MOIETY | 4E862E7GRQ | PYROPHOSPHATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ANAZAOHEALTH CORPORATION] | 1 | |
| STANNOUS CHLORIDE | INACTIVE INGREDIENT | 1BQV3749L5 | PYROPHOSPHATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ANAZAOHEALTH CORPORATION] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51808-218 | PYROPHOSPHATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ANAZAOHEALTH CORPORATION] | 1 | Legacy NDC, 1 package rows | 20121015_30046b6b-09ea-46b1-8e60-61c53e1e7282.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 51808-218-01 | 51808021801 | 1 in 1 KIT | Historical |